What we know about neurons.
Neurons, also called nerve cells, are the basic building blocks of our nervous system. Without them we could neither think, feel nor move. and has specific characteristics that make them unique.
Neurons, also called nerve cells, are the basic building blocks of our nervous system. Without them we could neither think, feel nor move. and has specific characteristics that make them unique.
In this video, Prof. Ceballos-Baumann sheds light on modern approaches to treating Parkinson's disease - what is really helpful and what are just exaggerated trends?
He takes a critical look at various alternative and experimental therapies such as acupuncture, the use of cannabis and advanced techniques such as cell transplantation.
We discuss which of these methods are supported by scientific studies and which are more in the realm of hope and hype. The aim is to provide a clear overview of the opportunities and limitations of these therapy options.
The Parkinson School offers comprehensive support and information for people with Parkinson's and their families. As one of the original main goals of the Parkinson Verbund eV, the Parkinson Journal has taken on the task of realizing this.
The result is a unique series of lectures that covers the entire spectrum of topics related to our disease. The series of lectures aims to educate participants about Parkinson's disease and to deepen their knowledge. In online lectures lasting around one hour, all essential aspects of the disease are covered in order to enable those affected to meet their therapists and neurologists on an equal footing and to deal with the disease more confidently.
The lecture will focus on new approaches to on-demand medication for Parkinson's patients who are suffering from a decline in the effect of levodopa. These so-called off phases occur when the effect of levodopa wears off before the next regular dose can be taken. Those affected not only experience a deterioration in mobility, but also effects on mood, discomfort, pain perception and circulation.
Parkinson's is a neurological disease that affects the lives of millions of people worldwide, whether directly as sufferers or indirectly as relatives, carers or medical professionals. In this talk, we will strive to provide a comprehensive picture of Parkinson's, from the basics of the disease to current research and proven treatments.
Whether you are already familiar with Parkinson's or are new to the topic, I hope this talk provides you with valuable insights and helps you develop a deeper understanding of the Parkinson's world.
So, without any further delay, let’s dive in and learn more about this fascinating and important condition.
Parkinson's is a neurological disease that affects the lives of millions of people worldwide, whether directly as sufferers or indirectly as relatives, carers or medical professionals. In this talk, we will strive to provide a comprehensive picture of Parkinson's, from the basics of the disease to current research and proven treatments.
Whether you are already familiar with Parkinson's or are new to the topic, I hope this talk provides you with valuable insights and helps you develop a deeper understanding of the Parkinson's world.
So, without any further delay, let’s dive in and learn more about this fascinating and important condition.
When a person with Parkinson's or a relative wants to find out about a possible disease, accompanying symptoms play a crucial role. These can affect different parts of the body, including skin, skeleton, sensory organs and psyche. The severity and occurrence of these symptoms vary from person to person, and it is important to note that some symptoms may have other causes.
The increased risk of melanoma in Parkinson's patients has been documented in numerous scientific studies. A first comprehensive meta-analysis was published by Liu and colleagues in the journal Neurology in 2011 and found that people with Parkinson's had more than double the risk of being diagnosed with melanoma. An important study on this topic was also published in 2010 by John Bertoni and colleagues in the Archives of Neurology (later renamed JAMA Neurology). The Bertoni study used data from the North American Parkinson's and Melanoma Survey Group and found that the incidence of malignant melanoma was 2,24 times higher in the Parkinson's cohort compared to the general population.
.The following is only about the GKV.Currently1 there are 113 statutory health insurance companies in Germany with approx. 71,4 million insured persons and family members.